{"nctId":"NCT00068822","briefTitle":"Vertebroplasty for the Treatment of Fractures Due to Osteoporosis","startDateStruct":{"date":"2003-04"},"conditions":["Spinal Fractures","Osteoporosis"],"count":131,"armGroups":[{"label":"Vertebroplasty","type":"EXPERIMENTAL","interventionNames":["Device: Percutaneous vertebroplasty"]},{"label":"Control Group","type":"PLACEBO_COMPARATOR","interventionNames":["Procedure: Sham vertebroplasty"]}],"interventions":[{"name":"Percutaneous vertebroplasty","otherNames":[]},{"name":"Sham vertebroplasty","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Confirmed osteoporosis or osteopenia by a referring physician and/or medical history and physical exam OR osteopenia on plain film\n* Vertebral compression fracture in vertebrae T4 through L5, of less than 1 year old\n* Pain not responsive to standard medical therapy\n* Current rating for pain intensity of at least 3 on a scale of 0 to 10\n\nExclusion Criteria:\n\n* Evidence or suspicion of malignant tumor or spinal canal compromise\n* Concomitant hip fracture\n* Local or systemic infection\n* Uncorrectable bleeding diatheses\n* Surgery within the previous 60 days\n* Lack of access to telephone\n* Inability to communicate in English\n* Dementia\n* Pregnancy\n* Abnormal renal function or anticipated venography\n* Conscious sedation is contraindicated for subject","healthyVolunteers":false,"sex":"ALL","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Back-specific Functional Status Using Roland-Morris Disability Questionnaire (RDQ) Scale at 1 Month","description":"Back-specific functional status using RDQ scale range from 0 (no pain) to 23, with higher scores indicating more severe disability.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.0","spread":"6.3"},{"groupId":"OG001","value":"13.0","spread":"6.4"}]}]}]},{"type":"SECONDARY","title":"Patient Well-being at 1 Month","description":"Patient well-being was quantified by these tools: Health status outcome using Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36). Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36), version 2. Subjects completed the SF-36 which consists of 8 sub-scales which are additionally summarized into 2 summary components (physical and mental). The subscales and the summary scales both range from 0 to 100, with (0 = worst imaginable, 100 = best imaginable).\n\nPain Frequency Index, Pain Bothersome Index (scores range from 0-4, higher scores indicating more severe pain).\n\nEuropean Quality of Life (QOL) 5 Dimensions (EQ-5D), scale range -0.1 to 1.0; higher scores indicating a better QOL.\n\nStudy of Osteoporotic Fractures-Activities of Daily Living (SOF ADL6) range from 0 to 18; higher scores = more back-related disability.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.7","spread":"9.6"},{"groupId":"OG001","value":"28.7","spread":"8.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.9","spread":"12.0"},{"groupId":"OG001","value":"45.6","spread":"14.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":"1.2"},{"groupId":"OG001","value":"2.3","spread":"1.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"1.1"},{"groupId":"OG001","value":"2.1","spread":"1.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.70","spread":"0.18"},{"groupId":"OG001","value":"0.64","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.7","spread":"3.7"},{"groupId":"OG001","value":"8.2","spread":"3.6"}]}]}]},{"type":"PRIMARY","title":"Patient's Rating of Average Pain at 1 Month","description":"Patient's rating of average pain intensity during the preceding 24 hours at 1 month. The rating scale was from 0 to 10, with higher scores indicating more severe pain.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":"2.9"},{"groupId":"OG001","value":"4.6","spread":"3.0"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":68},"commonTop":[]}}}